Groundbreaking discovery that'll see autism diagnoses skyrocket... with one group of Americans hit the hardest
The latest research out of Princeton University and the Simons Foundation uncovered four unique subtypes of autism, each with its own genetic 'fingerprint' - finally explaining why some children show signs early while others aren't diagnosed until school age.
Your browser does not support iframes. Your browser does not support iframes. Your browser does not support iframes.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
an hour ago
- Daily Mail
Real Housewives Of Orange County star emotionally reveals 10-year-old son's rare eating disorder diagnosis
The Real Housewives of Orange County 's Emily Simpson was overcome with emotion when she recently revealed that her young son Luke has been diagnosed with a rare eating disorder. The reality TV personality, 49, opened up about her son's diagnosis of Avoidant/Restrictive Food Intake Disorder (ARFID) during an interview with People. She broke the news shortly after another RHOC star, Tamra Judge, was called out for falsely saying that she had been diagnosed with autism. Before Emily's son's diagnosis, she had always just assumed he was just a picky eater, she told the outlet. 'He only eats a few different foods and he's very overwhelmed by texture, color, smells. He will only eat white rice,' Simpson, 49, said of what Luke's main symptoms are. 'And he has to inspect each piece of rice before he eats it. So it's beyond picky eating. A lot of control issues. It's very overwhelming.' Emily shared that prior to learning about her son's condition, he would often say he was 'starving' — because he was — but would still 'refuse to eat.' 'As a mom, that was so frustrating,' she confessed. 'I didn't know what to do because on one hand he's crying and telling me he's starving, and on the other hand, he refuses to eat anything that I offer.' The condition causes a person to lose interest in eating over anxiety–filled fears of choking, vomiting or a need to avoid unwanted colors, taste, textures or smells of different foods, per the Cleveland Clinic. The Bravo star said that every day is still 'challenging' but she tries to put herself in Luke's 'shoes.' 'Smells are extremely overwhelming for him. Color is overwhelming for him. Textures of food are overwhelming and make him gag,' the reality star said. 'So I have to constantly remind myself that he doesn't operate neurologically like we do.' The Cleveland Clinic states that treatment options include cognitive behavioral therapy and medications like antipsychotic medications, antidepressants or others that stimulate a person's appetite. Emily also took to Instagram to share her thanks to those who reached out to her after the People article was published. 'Hello Friends! ❤️❤️, she began. 'First, thank you so much for your support, kindness and love regarding Luke. 'This was by far my most difficult season filming RHOC I've ever had, and there were multiple times I felt that it was in Luke's best interest for me to quit. 'My reason for continuing on and navigating this truly challenging time (in real time and on camera) was because I knew I'd get more answers, support and feedback than any therapist or doctor could provide. 'The Bravo fans are incredible and caring people, and I wasn't wrong,' she continued. 'Thank you for the information and support you are all sending my way! Please keep it coming and please talk to your children about being kind to the kids who might be a little different ❤️❤️.' She concluded by throwing it back to RHOC, 'Secondly, what did you think of episode one?!' Fans will see her face Luke's diagnosis in real time, since it happened while she was filming season 19 of RHOC. 'There were lots of times I didn't even know if I could continue to film,' she said. '[Husband] Shane and I are learning every day how to navigate it.' Emily said Luke is currently in therapy and working with a nutritionist. And his diet has expanded to include not only rice but also. french fries, sliced bananas, potato chips, ice cream and plain turkey that 'doesn't have any lines or blemishes in it.' The worried mom admitted that its not easy to tread the line between trying to get him to eat new foods and not making him feel bad that he doesn't want to. Emily and Shane are also parents to son Keller, 10, daughter Annabelle, 12, and Shane's daughters from his first marriage — Chanel, 19, and Shelby, 24.
Daily Mail
2 hours ago
- Daily Mail
Common breast cancer treatment could reduce risk of developing Alzheimer's, research suggests
Women who undergo a common breast cancer treatment may have a lower risk of developing Alzheimer's disease, research suggests. The neurodegenerative disorder – which affects memory, thinking and behaviour – impacts more than 900,000 people in the UK. There is currently no cure and most cases of the condition are not linked to genetics. But scientists in South Korea have found that breast cancer patients treated with radiotherapy were significantly less likely to go on to develop Alzheimer's than women who hadn't received the treatment. Around one in seven women in the UK will be diagnosed with breast cancer during their lifetime. More than 70 per cent will be treated with radiotherapy, which uses high-energy radiation to kill cancer cells and shrink tumours. To investigate whether cancer treatment affects Alzheimer's risk, researchers at Samsung University analysed health records of more than 250,000 women. Around 70,000 were breast cancer survivors who had undergone surgery and treatment between 2010 and 2016. They found those who received radiotherapy were 8 per cent less likely to develop Alzheimer's than women who either hadn't had the treatment or had never had breast cancer. 'Based on these findings, we hypothesise that the risk of Alzheimer's dementia could be lowered shortly after cancer treatment,' said lead author Dr Su-Min Jeong. However, he added that this apparent protective effect faded with time. 'It may equalise as the survival period increases,' he said. Researchers believe radiotherapy may have anti-inflammatory or neuroprotective effects. It's also been shown to reduce levels of two types of brain cells linked to inflammation in Alzheimer's. Other theories suggest radiation may interfere with the formation of amyloid plaques – abnormal protein clumps found in the brains of Alzheimer's patients – or influence the immune system.
Medical News Today
3 hours ago
- Medical News Today
What to know about the Nimbus COVID-19 variant
The Nimbus variant, or NB.1.8.1, is a strain of SARS-CoV-2, which causes COVID-19. Alongside the usual symptoms of COVID-19, it can cause a razor blade sensation in the throat and gastrointestinal symptoms, such as nausea and vomiting. Although research on this variant is limited, it does not appear to result in more severe illness with COVID-19, and the currently approved vaccines are still is it?NB.1.8.1, unofficially named Nimbus, is a variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19).It is currently listed as a 'variant under monitoring' (VUM) by the World Health Organization (WHO). Since the beginning of the COVID-19 pandemic, the World Health Organization (WHO) has been keeping track of different variants of SARS-CoV-2. The WHO assesses the variants and designates them as one of the following:VUM: This refers to SARS-CoV-2 variants that may require attention and monitoring. The WHO aims to determine whether these variants pose an additional threat to global public health compared to the other of Interest: A VOI refers to SARS-CoV-2 variants with changes that can affect how the virus behaves and its potential impact on a person's health. This could include its ability to spread and cause serious disease, and how it can be detected and of Concern: A VOC refers to SARS-CoV-2 variants that meet the criteria of a VOI and meet one or more of the following criteria: spreads rapidlycauses more severe diseasechanges in clinical presentationescapes the body's immune responsedecreases the effectiveness of public health measures, diagnostics, vaccines, or treatmentsWhat are the symptoms?According to the Global Alliance for Vaccines and Immunizations (Gavi), the symptoms of the NB.1.8.1 variant are essentially the same as the symptoms of the Omicron variant of SARS-CoV-2. The top five reported symptoms of the Omicron variant are:runny noseheadachefatiguesneezingsore throatHealthcare professionals in India report that it can cause a hoarse voice. Additionally, doctors in the United Kingdom warn that people may experience a razor blade sensation in the throat and gastrointestinal symptoms, including:nauseavomitingdiarrheaheartburnbloatingconstipationstomach painHowever, it is important to note that these symptoms have not been confirmed in scientific symptoms of COVID-19 include:coughshortness of breathnew loss of taste or smellmuscle and body achesheadacheWill it cause a more severe illness with COVID-19?The WHO has concluded that there is currently no evidence to suggest that this variant will result in more severe illness with COVID-19 than other also state that it does not appear to cause any additional public health risks and that it is not resistant to nirmatrelvir, an antiviral medication made by Pfizer to help treat COVID-19. This medication is combined with another antiviral called ritonavir under the brand name quickly does it spread?Although it does not appear to cause more severe illness with COVID-19, the NB.1.8.1 variant has evolved to spread to 2025 research, the NB.1.8.1 variant strongly binds to a human protein called ACE2. The virus uses this protein to enter human could be due to changes in its structure. Compared to earlier versions of the virus, it has seven changes in the spike protein, which is the part of the virus that attaches to human vaccines still effective against it?The WHO's risk evaluation states that the currently approved COVID-19 vaccines are still expected to be effective against this evaluation outlines one study that found that the NB.1.8.1 variant showed a 1.5- to 1.6-fold reduction in antibody effectiveness compared to the current most common COVID-19 variant. However, the WHO states that more research is necessary, and the current vaccines will still be explainedAntibodies are Y-shaped proteins that are a part of the immune system. The base of an antibody can communicate with other parts of the immune system, and the tip of an antibody binds to foreign invaders, such as bacteria and viruses, called antigens, to help the body eliminate it learns to recognize an antigen, the antibodies continue to circulate in the body and provide protection against future exposure to that particular the FDA has approved the following COVID-19 vaccines in the United States:Moderna (Spikevax)Comirnaty (Pfizer-BioNTech)The FDA has also authorized the following COVID-19 vaccines for emergency use:Moderna COVID-19 vaccine for individuals 6 months to 11 years of agePfizer-BioNTech COVID-19 Vaccine for individuals 6 months to 11 years of ageNovavax (Nuvaxovid) for those ages 12 and over»Learn more:COVID-19 vaccines and current recommendationsSummaryThe unofficially named Nimbus variant, or NB.1.8.1, is a new strain of SARS-CoV-2. It appears to cause symptoms similar to another SARS-CoV-2 variant called Omicron. According to reports from doctors in the UK, it can cause a razor-blade sensation in the throat. Healthcare professionals in India report that it can cause a hoarse voice and gastrointestinal symptoms. NB1.8.1 is currently classed as a VUM by the WHO. This means that it is a variant that they will continue to monitor to see if it poses an additional threat to global public it does not appear to cause more severe illness with COVID-19, although it has evolved to spread quickly. The currently-approved vaccines are expected to remain effective against the NB.1.8.1 variant.
